Lawless Beauty Is Adding a Full-coverage Foundation to Its TikTok-viral Forget the Filler Line
Formulated with more than 40 percent skin care ingredients, the foundation aims to emphasize both color payoff and skin care ...
Contract Pharma2d
Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials
New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...
Managed Healthcare Executive4d
FDA Sets Review Date for Linvoseltamab for Multiple Myeloma
The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
Regeneron Gets New FDA Review of Linvoseltamab for Multiple Myeloma
Regeneron, which is seeking FDA approval of linvoseltamab for adults with relapsed/refractory multiple myeloma that has progressed after at least three prior therapies, said the agency set a new ...
Regeneron announces FDA acceptance of BLA for linvoseltamab
Regeneron (REGN) announced that the U.S. Food and Drug Administration has accepted for review the resubmission of the Biologics License ...
The Manila Times4d
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Linvoseltamab is an investigational BCMAxCD3 bispecific antibody designed to bridge B-cell maturation antigen (BCMA) on MM cells with CD3-expressing T cells to facilitate T-cell activation and ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
Union of European Football Associations16d
Champions League round of 16 and knockout phase play-offs: Who has qualified?
Liverpool and Barcelona were the first teams to secure their places in the 2024/25 UEFA Champions League round of 16 and six other sides have now confirmed their berths. The Reds had already ...
Business Insider16d
Regeneron: Strong Buy Rating Driven by Dupixent’s Growth and Promising Pipeline Developments
Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at $1,100.00. Chris Schott has given his Buy rating due to a ...